Adicet Bio appoints Stewart Abbot, Ph.D. as Chief Scientific Officer
MENLO PARK, Calif., June 27, 2018 -- (Healthcare Sales & Marketing Network) -- Adicet Bio, Inc. ("Adicet"), a biopharmaceutical company focused on the development of next-generation immunotherapies, announced today that it has appointed Stewart ... Biopharmaceuticals, Oncology, Personnel Adicet Bio, universal immune cell therapies, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 27, 2018 Category: Pharmaceuticals Source Type: news

ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP
BAUDETTE, Minn., June 27, 2018 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Cholestyramine for Oral Suspension USP, 4g/dose, in cans. The current annual U.S. market ... Biopharmaceuticals, Product Launch ANI Pharmaceuticals, cholestyramine, hypercholesterolemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 27, 2018 Category: Pharmaceuticals Source Type: news

AcelRx receives European Commission approval for DZUVEO(TM)
AcelRx's DZUVEO receives EU approval for management of acute moderate to severe pain in medically monitored settings REDWOOD CITY, Calif., June 27, 2018 -- (Healthcare Sales & Marketing Network) -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx o... Biopharmaceuticals, Drug Delivery, Regulatory AcelRx Pharmaceuticals, DZUVEO, DSUVIA , sufentanil, sublingual (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 27, 2018 Category: Pharmaceuticals Source Type: news

Carisma Therapeutics Announces a $53 Million Series A Financing to Develop Novel CAR Macrophage Cellular Immunotherapy
Initial applications to focus on the treatment of solid tumor malignancies Clinical trials expected to begin in 2019 PHILADELPHIA, June 27, 2018 -- (Healthcare Sales & Marketing Network) -- Carisma Therapeutics Inc., formerly CARMA Therapeutics, a p... Biopharmaceuticals, Venture Capital Carisma Therapeutics, macrophage, immunotherapeutics, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 27, 2018 Category: Pharmaceuticals Source Type: news

Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
Company to open corporate headquarters in Minneapolis, MN MINNEAPOLIS, June 26, 2018 -- (Healthcare Sales & Marketing Network) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back ... Devices, Orthopaedic, Neurosurgery, Venture Capital Relievant Medsystems, low back pain, Intracept, basivertebral nerve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 26, 2018 Category: Pharmaceuticals Source Type: news

Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)
Salix Sales Force to Begin Promoting LUCEMYRA to Primary Care and Pain Management Physicians LUCEMYRA is the First and Only Non-Opioid Medication Approved for Mitigation of Opioid Withdrawal Symptoms 08:00 ET from US WorldMeds LOUISVILLE, Ky. and... Biopharmaceuticals, Distribution US WorldMeds, Salix Pharmaceuticals, LUCEMYRA, lofexidine, Opioid Withdrawal (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 26, 2018 Category: Pharmaceuticals Source Type: news

Sechrist Industries And Dartmouth's Geisel School Of Medicine Work Together To Bring Hyperbaric Oxygen Therapy To Tanzania
ANAHEIM, Calif., June 26, 2018 -- (Healthcare Sales & Marketing Network) -- Sechrist Industries, Inc. has partnered with Jay Buckey, MD, Professor of Medicine at Dartmouth College's Geisel School of Medicine, to bring Hyperbaric Oxygen Therapy (HBOT) to T... Devices Sechrist Industries, hyperbaric oxygen, hyperbaric therapy, hyperbaric chamber (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 26, 2018 Category: Pharmaceuticals Source Type: news

AbbVie and Calico Announce Extension of Groundbreaking Collaboration
Extension builds on collaboration established in 2014 Collaboration focuses on aging and age-related diseases, including neurodegeneration and cancer NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif., June 26, 2018 -- (Healthcare Sales & Marketing ... Biopharmaceuticals, Neurology, Oncology AbbVie, Calico , neurodegeneration, cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 26, 2018 Category: Pharmaceuticals Source Type: news

InfuSystem Holdings, Inc. Selected as an Official Distributor of CADD(R) Infusion Therapy Products by Smiths Medical
MADISON HEIGHTS, Mich., June 26, 2018 -- (Healthcare Sales & Marketing Network) -- InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national provider of infusion pumps and related services for ... Devices, Distribution InfuSystem Holdings, Smiths Medical, CADD infusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 26, 2018 Category: Pharmaceuticals Source Type: news

Caris Life Sciences Expands Management Team
Meeting the needs of a complex and growing market Brian Brille, experienced financial services executive joins as Vice Chairman, leading corporate and business development, M&A and capital markets Seasoned healthcare executives Michael Sullivan and N... Diagnostics, Personnel Caris Life Sciences, ADAPT Biotargeting System, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 26, 2018 Category: Pharmaceuticals Source Type: news

IMBRUVICA(R) (ibrutinib) Supplemental New Drug Application Accepted for Review by U.S. FDA with Potential to Broaden Treatment Use as a Combination Treatment Option with Rituximab in Waldenström's Macroglobulinemia (WM), A Rare Form of Blood Cancer
The filing is based on data from the Phase 3 iNNOVATE study, which suggest that IMBRUVICA plus rituximab may improve outcomes across all lines of Waldenström's macroglobulinemia (WM) treatment, including patients with prior lines of therapy and variou... Biopharmaceuticals, Oncology, FDA AbbVie, IMBRUVICA, ibrutinib, Waldenström's Macroglobulinemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2018 Category: Pharmaceuticals Source Type: news

Beckman Coulter Files a 510(k) Submission with the FDA for Its Early Sepsis Indicator*
Offered as part of a routine CBC with differential test, the hematology-based solution is intended to alert emergency department clinicians to sepsis or the possibility of sepsis earlier than any other indicator BREA, Calif., June 25, 2018 -- (Healthca... Diagnostics, FDA Beckman Coulter, Early Sepsis Indicator, Sepsis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2018 Category: Pharmaceuticals Source Type: news

Radiation oncologists urge Congress to protect patient access to cancer care
WASHINGTON, June 25, 2018 -- (Healthcare Sales & Marketing Network) -- Radiation oncologists from across the United States will visit Capitol Hill tomorrow to urge Congress to support policies that safeguard cancer patients' access to high-quality, high-va... Devices, Oncology, Reimbursement American Society for Radiation Oncology, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2018 Category: Pharmaceuticals Source Type: news

Cronos Group Inc. Announces Exclusive Distribution Agreement with Delfarma in Poland
TORONTO, June 25, 2018 -- (Healthcare Sales & Marketing Network) – Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), is pleased to announce that it has entered into a strategic distribution partnership wi... Biopharmaceuticals, Distribution Cronos Group, Delfarma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2018 Category: Pharmaceuticals Source Type: news

Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases
Financing led by Apple Tree Partners, Atlas Venture, venBio Partners and Versant Ventures Company Announces Licensing Agreement with Amgen CAMBRIDGE, Mass., June 25, 2018 -- (Healthcare Sales & Marketing Network) -- Akero Therapeutics, Inc., a biote... Biopharmaceuticals, Licensing, Venture Capital Akero Therapeutics, Amgen, non-alcoholic steatohepatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2018 Category: Pharmaceuticals Source Type: news

DelMar Pharmaceuticals Appoints World-Renowned Molecular Biologist Dr. Napoleone Ferrara to Board of Directors
VANCOUVER, British Columbia and MENLO PARK, Calif., June 25, 2018 -- (Healthcare Sales & Marketing Network) -- DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the developm... Biopharmaceuticals, Personnel DelMar Pharmaceuticals, angiogenesis, VEGF (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2018 Category: Pharmaceuticals Source Type: news

FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea
Novel Low-Flow Technology Has Demonstrated Efficacy in Obstructive Sleep Apnea Patients SAN CLEMENTE, Calif., June 25, 2018 -- (Healthcare Sales & Marketing Network) -- FRESCA Medical, Inc., a privately held sleep solutions and connected health company... Devices, FDA FRESCA Medical, CURVE System, Positive Airway Pressure, sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2018 Category: Pharmaceuticals Source Type: news

Nordic Nanovector Appoints Eduardo Bravo as Chief Executive Officer
OSLO, 25 June, 2018 -- (Healthcare Sales & Marketing Network) -- Nordic Nanovector ASA (OSE: NANO) announces that Eduardo Bravo has been appointed as its Chief Executive Officer. Mr. Bravo brings more than 25 years' experience in the biopharmaceutical ... Biopharmaceuticals, Oncology, Personnel Nordic Nanovector, Betalutin, non-Hodgkin's lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2018 Category: Pharmaceuticals Source Type: news

William A. Haseltine, PhD Joins Grace Therapeutics' Board of Directors
Pioneering Scientist and Former CEO of Human Genome Sciences Brings Key Expertise to Grace's Board EAST BRUNSWICK, N.J., June 22, 2018 -- (Healthcare Sales & Marketing Network) -- Grace Therapeutics, a clinical stage biopharmaceutical company focused o... Biopharmaceuticals, Neurology, Personnel Grace Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2018 Category: Pharmaceuticals Source Type: news

Elizabeth O'Farrell Named to PDL BioPharma's Board of Directors
INCLINE VILLAGE, Nev., June 22, 2018 -- (Healthcare Sales & Marketing Network) -- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) announced today that retired Eli Lilly and Company executive Elizabeth G. O'Farrell has been ... Biopharmaceuticals, Devices, Personnel PDL BioPharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2018 Category: Pharmaceuticals Source Type: news

Lilly Completes Acquisition of ARMO BioSciences
INDIANAPOLIS, June 22, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of ARMO BioSciences, Inc. (NASDAQ: ARMO). Lilly's tender offer for all outstanding s... Biopharmaceuticals, Mergers & Acquisitions Eli Lilly, ARMO BioSciences, pegilodecakin, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2018 Category: Pharmaceuticals Source Type: news

Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
SEATTLE, June 22, 2018 -- (Healthcare Sales & Marketing Network) -- Impel NeuroPharma, a Seattle-based, privately-held biotechnology company focused on therapies for the treatment of central nervous system (CNS) disorders, today announced that the U.S. Fo... Biopharmaceuticals, Drug Delivery, Neurology, FDA Impel NeuroPharma, Precision Olfactory Delivery, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2018 Category: Pharmaceuticals Source Type: news

Replimune Appoints Dieter K. Weinand to Board of Directors
WOBURN, Massachusetts, June 22, 2018 -- (Healthcare Sales & Marketing Network) -- Replimune Group Inc., a biotechnology company developing next generation oncolytic immunotherapies, announced today it has appointed Dieter K. Weinand to its Board as an ind... Biopharmaceuticals, Oncology, Personnel Replimune, oncolytic immunotherapies, Immulytic, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2018 Category: Pharmaceuticals Source Type: news

PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma
TAIPEI, Taiwan, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- PharmaEngine Inc. (TWO: 4162) and its corporate partner, Nanobiotix S.A. (Euronext: NANO) announced today that PEP503 (NBTXR3) in combination with radiotherapy met the primary endp... Biopharmaceuticals, Oncology PharmaEngine, Nanobiotix, soft tissue sarcoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2018 Category: Pharmaceuticals Source Type: news

Sera Prognostics Appoints Dr. Garrett K. Lam as Chief Medical Officer
Maternal fetal medicine expert joins Sera to improve pregnancy health globally SALT LAKE CITY, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that Garrett K. Lam, M.D., FA... Diagnostics, OB/GYN, Personnel Sera Prognostics, PreTRM, preterm birth (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris Pharmaceuticals Co.
Capital will fuel continued research and clinical development of micro-infusion platform EMERYVILLE, Calif., June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Mercator MedSystems, Inc., today announced it has received $11 million in Series D e... Devices, Interventional, Venture Capital Mercator MedSystems, Shenzhen Salubris Pharmaceuticals, Bullfrog, Micro-Infusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

AdoRx Therapeutics Announces Initial Funding of $10 Million for the Discovery of New Cancer Therapeutics
EDINBURGH, Scotland, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- AdoRx Therapeutics, a UK based drug discovery company focused on the identification of new cancer therapeutics, today announced that it has closed an initial $10 million inves... Biopharmaceuticals, Oncology, Venture Capital AdoRx Therapeutics, adenosine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

Alimera Sciences Appoints Mary T. Szela to its Board of Directors
Ms. Szela brings extensive global brand experience to the Alimera Board ATLANTA, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescripti... Biopharmaceuticals, Ophthalmology, Personnel Alimera Sciences, retinal disease, retina (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

Accuray Receives AERB Approval for Sale and Supply of its Radixact(R) X9 System in India
SUNNYVALE, Calif., June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company has received an Atomic Energy Regulatory Board (AERB) Type Approval for its Radixact® X9 System in India... Devices, Oncology, Regulatory Accuray, Radixact X9, TomoTherapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

Caris Life Sciences Presents Data Demonstrating the Ability of ADAPT Biotargeting System to Identify Responders and Non-Responders in a Phase III Pancreatic Cancer Study
Leveraging ADAPT Biotargeting System would have significantly increased the probability of success Data presented at the ESMO World Congress on Gastrointestinal Cancer 2018 IRVING, Texas, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Ca... Diagnostics, Oncology Caris Life Sciences, ADAPT Biotargeting System, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
Delivering Commitment to Find New Treatment Options for Patients Suffering from Sacral Insufficiency Fractures DUBLIN - June 20, 2018- Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of ... Devices, Interventional, Radiology, Orthopaedic, FDA Medtronic, Kyphon, Kyphon HV-R, Bone Cement, Sacral Insufficiency (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
Trial Will Investigate Company's Platform Cancer Immunotherapy in Patients with The Deadliest Form of Brain Cancer IRVINE, Calif., June 20, 2018 -- (Healthcare Sales & Marketing Network) -- AIVITA Biomedical, a biotech company specializing in innovativ... Regenerative Medicine, Oncology, FDA AIVITA Biomedical, glioblastoma multiforme, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Belmont Instrument, LLC Announces the Acquisition of MTRE Advanced Technologies Ltd.
BILLERICA, Mass., June 20, 2018 -- (Healthcare Sales & Marketing Network) -- Belmont Instrument, LLC ("Belmont") announced it has acquired MTRE Advanced Technologies Ltd. ("MTRE") product lines from Mennen Medical Ltd. MTRE, headquarte... Devices, Mergers & Acquisitions Belmont Instrument, MTRE Advanced Technologies, Mennen Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
VANCOUVER, June 20, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, ... Devices, Interventional, Cardiology Neovasc, Reducer, angina (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
BRIDGEWATER, N.J., June 20, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a specialty pharmaceutical company, today announced that it has entered into a settlement agreement with Actavis Laboratories FL, Inc.... Biopharmaceuticals, Generics, Litigation Amneal Pharmaceuticals, Actavis Laboratories FL, Actavis Pharma, Rytary (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Steba Biotech's TOOKAD(R) Vascular Photodynamic Therapy Maintains Significant Reduction in Overall Progression and Conversion to Radical Therapy in Low-risk Prostate Cancer Patients at 4 Years
LUXEMBOURG, June 20, 2018 -- (Healthcare Sales & Marketing Network) -- Steba Biotech, a privately-owned biotechnology company focused on the development of innovative and minimally invasive photodynamic therapies and systems to treat cancers, today announ... Biopharmaceuticals, Urology, Oncology Steba Biotech, photodynamic therapy, TOOKAD, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
Grifols Procleix Ultrio Elite assay screens for HIV-1, HCV, and HBV and detects HIV-2; the Procleix WNV assay screens for West Nile virus Both assays are approved to run on the fully automated NAT blood screening platform Procleix Panther system Thes... Diagnostics, FDA Grifols, Procleix Ultrio Elite, Procleix WNV, HIV-1, HCV (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

Avantis Medical Names Matt Frushell as President and CEO, Salmaan Hameed as CTO, as Company Moves to Full Commercial Operation
Management team will work closely with PENTAX Medical to commercialize Third Eye Panoramic cancer detection device in U.S. SAN JOSE, Calif., June 19, 2018 -- (Healthcare Sales & Marketing Network) -- Marking the company's move from development phase to... Devices, Diagnostics, Oncology, Personnel Avantis Medical Systems, PENTAX Medical, Third Eye Panoramic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

Orbis Biosciences(R) announces New Management Hires with addition of Chief Licensing Officer and Vice President of Business Development
KANSAS CITY, Mo., June 19, 2018 -- (Healthcare Sales & Marketing Network) -- Orbis Biosciences is pleased to announce and welcome Karl Strohmeier as Chief Licensing Officer and Brad Spitz as Vice President of Business Development. These two associates br... Biopharmaceuticals, Drug Delivery, Personnel Orbis Biosciences, Optimμm, Stratμm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
Now Offering Both Phenotype and Genotype Testing for Antibiotic Resistance SAN DIEGO and Irvine, Calif., June 19, 2018 -- (Healthcare Sales & Marketing Network) -- GenomeDx Biosciences and Pathnostics today announced the launch of the next generation G... Diagnostics, Oncology, Product Launch GenomeDx Biosciences, Pathnostics, prostate cancer, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

Alpha Biopharma Announces Series A Financing
SHANGHAI, June 19, 2018 -- (Healthcare Sales & Marketing Network) -- Alpha Biopharma Inc. ("AlphaBio") today announced the first $37M closing of its $65M Series A financing led by Qiming Venture Partners, one of the most prominent venture capita... Biopharmaceuticals, Oncology, Venture Capital, Personnel Alpha Biopharma, NSCLC, tyrosine kinase inhibitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

Albireo Appoints Jason G. Duncan as General Counsel and Secretary
BOSTON, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the appointment of Jason G. Duncan as Gene... Biopharmaceuticals, Personnel Albireo Pharma, bile acid modulator, liver disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Elekta Unity, World's First High-Field MR-Linac, Receives CE Mark
STOCKHOLM, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- New radiation therapy system will now be implemented clinically in Europe, ushering in a transformation in precision and personalized cancer treatment Elekta (EKTA-B.ST) earlier toda... Devices, Oncology, Radiology, Regulatory Elekta, Elekta Unity, magnetic resonance, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Arcuro Medical Receives FDA Regulatory Clearance
MISGAV, Israel, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Arcuro Medical Ltd. ("Arcuro"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced today that it received regu... Devices, Orthopaedic, FDA Arcuro Medical, SuperBall, meniscus repair, Meniscus tear (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Theranos Announces Management Transition
NEWARK, Calif., June 18, 2018 -- (Healthcare Sales & Marketing Network) -- The Board of Directors of Theranos, Inc., announced today that Elizabeth Holmes has stepped down as Chief Executive Officer and David Taylor, the Company's General Counsel, has bee... Diagnostics, Personnel Theranos (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer
CARLSBAD, Calif., June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Damien McDevitt, Ph.D. has joined the company as chief business officer. In his role, Dr. McDevitt will serve as a... Biopharmaceuticals, Personnel Ionis Pharmaceuticals, SPINRAZA, nusinersen, TEGSEDI, inotersen, WAYLIVRA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Rheumatoid Arthritis Phase 4 Clinical Trial Data Recently Presented at the Annual European Congress of Rheumatology (EULAR 2018) Multiple Sclerosis Relapse Observational Registry Data Recently Presented at the 2018 Annual Meeting of the Consortium of Mu... Biopharmaceuticals Mallinckrodt, H.P. Acthar Gel, Rheumatoid Arthritis, Multiple Sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study
STOCKHOLM, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) today announced that the Board of Directors have decided to continue the discussions with the US Food and Drug Administration (FDA) to agree on the d... Biopharmaceuticals, Oncology Medivir, remetinostat, cutaneous T-cell lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Medtronic Receives FDA Approval for 200mm and 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
New, Extended Balloon Lengths Enable Physicians to Efficiently Treat Long SFA Lesions DUBLIN - June 15, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths of... Devices, Interventional, FDA Medtronic, IN.PACT Admiral, Drug-Coated Balloon, peripheral artery disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2018 Category: Pharmaceuticals Source Type: news

MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress
Initiation of registration study for ME-401 in patients with relapsed or refractory follicular lymphoma expected before year-end SAN DIEGO, June 15, 2018 -- (Healthcare Sales & Marketing Network) -- MEI Pharma, Inc. (NASDAQ: MEIP) a pharmaceutical comp... Biopharmaceuticals, Oncology MEI Pharma, follicular lymphoma, chronic lymphocytic lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2018 Category: Pharmaceuticals Source Type: news